Arkolith/Insider Trading/ELVN/Form 4

Collins Helen Louise

CHIEF MEDICAL OFFICEREnliven Therapeutics, Inc. (ELVN) · full profile →Form 4 · filed Aug 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$293K
Net Open-Market Flow
-$293K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 17, 2026Option exercise(M)5K$2.48$12K30K
Aug 17, 2026Sell(S)4K$58.37$228K26K
Aug 17, 2026Sell(S)1K$59.35$65K25K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 17, 2026Option exercise(M)5K—$0111K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001701247-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Enliven Therapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp